SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Chris Delap who wrote (5424)2/11/1998 10:46:00 PM
From: Tunica Albuginea  Respond to of 23519
 
Chris, PFE does not have a rich pipeline of new, yet to be announced, drugs per my hospital pharmacist.That is, new drugs, after they introduce what they've already announced: Trovan, Viagra and 1 or 2 more; what's left after that is poor.Again, this is per my hospital pharmacist. I am not intereste in researching this. I do know however that other than Procardia there isn't enything that I can think off right now that has revoluyionized the way I practice.There are too many substitutes for EVERYTHING PFE makes.

TA